Clinical Trial Update: Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing adjuvant S-1 plus oxaliplatin to S-1 alone in locally advanced gastric cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Gastric Cancer | Phase 3 | Status: TERMINATED